hum0354 Release Note
| Research ID | Release Date | Type of Data |
|---|---|---|
| hum0354.v2 | 2023/04/18 | qRT-PCR using mRNA derived from CTC of patients with advanced metastatic castration-resistant prostate cancer undergoing drug treatment (enzalutamide) |
| hum0354.v1 | 2022/06/30 | qRT-PCR using mRNA derived from CTC of patients with advanced metastatic castration-resistant prostate cancer undergoing drug treatment (cabazitaxel) |
hum0354.v2
mRNAs extracted from circulating tumor cells (CTC) in peripheral blood samples of 46 patients with advanced metastatic castration-resistant prostate cancer undergoing drug treatment (enzalutamide) were performed qRT-PCR. The intensity of androgen receptor expression in CTC and the presence or absence of splicing variant 7 (AR-V7) were analyzed (xlsx files).
hum0354.v1
mRNAs extracted from circulating tumor cells (CTC) in peripheral blood samples of 48 patients with advanced metastatic castration-resistant prostate cancer undergoing drug treatment (cabazitaxel) were performed qRT-PCR. The intensity of androgen receptor expression in CTC and the presence or absence of splicing variant 7 (AR-V7) were analyzed (xlsx files).
Note：
